REGN Ownership
Regeneron Pharmaceuticals Inc - Institutional & insider holdings
Ownership Breakdown
Institutions
69+
Stock Price
$781.67
Top Institutional Holders
View All Holders →| Holder | Shares | Value | % Owned |
|---|---|---|---|
| Vanguard Group Inc | 9.42M | $7.50B | 889.17% |
| BlackRock Inc | 9.28M | $7.38B | 875.21% |
| JPMorgan Chase & Co | 3.94M | $3.13B | 371.71% |
| Dodge & Cox | 3.83M | $3.04B | 361.01% |
| FMR Inc | 3.33M | $2.65B | 313.91% |
| Geode Capital Management, LLC | 2.47M | $1.96B | 232.58% |
| Franklin Resources Inc | 2.31M | $1.84B | 218.28% |
| Invesco QQQ Trust | 2.19M | $1.74B | 206.43% |
| Loomis, Sayles & Company LP | 1.94M | $1.54B | 183.14% |
| Fidelity 500 Index | 1.32M | $1.05B | 124.20% |
| SPDR® S&P 500® ETF | 1.25M | $995.78M | 118.13% |
| iShares Core S&P 500 ETF | 1.25M | $993.62M | 117.87% |
| NORGES BANK | 1.20M | $951.61M | 112.89% |
| Amvescap Plc. | 1.08M | $855.65M | 101.50% |
| Putnam Large Cap Value A | 1.06M | $845.89M | 100.35% |
Recent Insider Trading
View All Insider Trades →Insider trading data for REGN is being updated.
Insider trades are reported via SEC Form 4.
Understanding Stock Ownership
Institutional Ownership
Large investors like hedge funds and mutual funds that manage $100M+ must disclose their holdings quarterly via 13F filings. High institutional ownership often indicates strong fundamentals.
Insider Ownership
Company executives and directors must report their trades via SEC Form 4. Insider buying can signal confidence, while selling may occur for various reasons including diversification.
Why It Matters
Ownership structure reveals who believes in the company. Institutional investors conduct deep research, while insider buying shows internal confidence. Track ownership changes for investment signals.
Data Sources
Institutional data from SEC 13F filings (quarterly), insider trades from Form 4 filings (within 2 business days), and company proxy statements (annual ownership disclosures).
Get Full REGN Analysis
AI insights, financials, valuation, and complete ownership tracking
View Complete AnalysisFrequently Asked Questions
Who owns REGN?
REGN (Regeneron Pharmaceuticals Inc) is owned by institutional investors (multiple), company insiders (various holdings), and retail investors. The largest institutional holders are disclosed in quarterly SEC 13F filings.
What is REGN institutional ownership?
REGN has significant institutional ownership from hedge funds, mutual funds, and investment firms. Check the holdings table above for detailed data.
What is REGN insider ownership?
Company insiders hold shares of REGN. Insider trading activity is tracked through SEC Form 4 filings.
Are REGN insiders buying or selling?
Check the insider trading activity section above for the latest REGN insider transactions.